Analytical Data
-
Gene name
DKKL1
- Application
-
Alternative Names
SGY-1; CT34; Cancer/Testis Antigen 34; Protein soggy-1
-
Species
Rat
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
D4A444
-
Expression Region
Val21~Leu230
-
Molecular Weight
32kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DKKL1 (Dapper, Dickkopf-like 1) is an important member of the DKK family, known for its role in the Wnt signaling pathway, which is crucial in regulating embryonic development, cell differentiation, and tissue homeostasis. Recent studies have highlighted DKKL1's involvement in various physiological processes and its potential implications in several pathological conditions, including cancer, cardiovascular diseases, and neurodegenerative disorders. Due to its significant biological functions, researchers have been keen on exploring DKKL1 as a biomarker for disease progression and as a target for therapeutic interventions. The production of recombinant DKKL1 protein has become essential for elucidating its molecular mechanisms and functions through in vitro and in vivo studies. By generating DKKL1 in a controlled environment, scientists can investigate its interactions with other signaling molecules, assess its effects on cell behavior, and analyze its role in modulating disease states. This research not only aims to deepen our understanding of DKKL1's biological significance but also strives to explore its potential utility in clinical applications, particularly in early diagnosis and targeted therapies.
